Dr. Narendra Agrawal
Sr. Consultant – Hemato Oncology & Bone Marrow Transplant, Hemato Oncology & Bone Marrow Transplant
About
Blood cancers, blood disorders and bone marrow transplants form the clinical focus of Dr. Narendra Agrawal, Sr. Consultant in Hemato Oncology & Bone Marrow Transplant at Rajiv Gandhi Cancer Institute & Research Centre, Sector-5, Rohini. He holds an M.B.B.S. from Ravindra Nath Tagore Medical College, Udaipur, and an M.D. from Jawahar Lal Nehru Medical College, Ajmer, both under the University of Rajasthan, and a D.M. (Hematology) from All India Institute of Medical Sciences, Delhi.
His listed conditions include blood cancers, acute leukaemia (AML and ALL), lymphoma, myeloma, myelodysplastic syndromes, anaemia, aplastic anaemia, bleeding disorders such as immune thrombocytopenia (ITP), coagulation disorders such as DVT, thalassaemia, other haemoglobin disorders and haemophilia. His procedures are allogeneic, haplo-identical and autologous bone marrow and stem cell transplants, and his special interests are acute lymphoblastic leukaemia (ALL) and multiple myeloma.
His published work, from 2015 to 2024, includes studies on imatinib adherence in chronic myeloid leukaemia, tuberculosis after allogeneic stem cell transplantation, stem cell transplantation for multiple myeloma, haploidentical transplantation for Philadelphia positive acute lymphoblastic leukaemia, and a systematic review of adult and adolescent acute lymphoblastic leukaemia in India.
Qualifications
Publications
Factors influencing adherence to imatinib in Indian chronic myeloid leukemia patients: a cross-sectional study
Incidence and clinical profile of tuberculosis after allogeneic stem cell transplantation
Autologous stem cell transplantation in first remission is associated with better progression-free survival in multiple myeloma
Outcome of Philadelphia Positive Acute Lymphoblastic LeukemiaWith or Without Allogeneic Stem Cell Transplantation in a Retrospective Study
Study of Haploidentical Stem Cell Transplantation for Philadelphia/BCR-ABL Positive Acute Lymphoblastic Leukemia
Retrospective institutional analysis of fludarabine/8 Gy TBI reduced intensity conditioning in high risk ALL
Systematic Review of the Burden and Treatment Patterns of Adult and Adolescent Acute Lymphoblastic Leukemia in India: Comprehending the Challenges in an Emerging Economy
Real World Outcome of B ALL with t (1; 19) (q23; p13)/TCF3::PBX1 in Adolescents and Adults Treated with Intensive Regimes
Conditions treated
Where they practise
BioTB TrustScore™ Analysis
Very GoodRanked #98 of 243 oncology specialists in New Delhi
Score breakdown
- Credentials & training (25%)8.5/10
postgraduate degree and super-specialty training
- Experience & seniority (20%)4.0/10
senior designation
- Hospital standing (20%)8.4/10
Rajiv Gandhi Cancer Institute & Research Centre and NABH and NABL accredited
- Practice depth (15%)10.0/10
3 procedures listed, 12 conditions treated and academic or award record
- Access & transparency (10%)3.0/10
direct contact number
- Profile completeness (10%)8.5/10
reviewed in the last 90 days
Strengths
- Practice depth: 3 procedures listed, 12 conditions treated and academic or award record
- Credentials & training: postgraduate degree and super-specialty training
- Profile completeness: reviewed in the last 90 days
Check before you visit
- Experience & seniority: senior designation
- Access & transparency: direct contact number
BioTB analysis
Dr. Narendra Agrawal ranks #98 of 243 oncology specialists in New Delhi on the BioTB TrustScore™, placing in the top 41%. The score of 7.3 (Very Good) is driven most by practice depth (10/10: 3 procedures listed, 12 conditions treated and academic or award record). The main gap is access & transparency (3/10: direct contact number), so confirm those details with the hospital before you visit.
TrustScore™ is computed by the BioTB analysis engine from the facts on this profile, weighted as shown above, and re-ranked against every other oncology specialist in New Delhi. How TrustScore™ works
Practice Location & Google Map
Address and map for this listing. Confirm before you visit.
D-18, Sector-5, Rohini, Delhi-110085
Patient Reviews0
No pay-to-rank.
BioTB TrustScore™
Computed by the BioTB analysis engine from this profile's facts and ranked against every doctor of the same specialty in New Delhi. Full analysis
Consultation details
Timings not listed. Call the clinic to confirm OPD days.
Every fact on this profile is sourced from the hospital or clinic's official website and other authoritative public pages, curated by the BioTB editorial team, scored by the TrustScore™ engine and dated at its last review. Rankings cannot be bought.
Where this information comes from
Last reviewed- Rajiv Gandhi Cancer Institute & Research Centre doctor profile (Hospital website, read 2026-10-20)
- Rajiv Gandhi Cancer Institute & Research Centre contact page (Hospital website, read 2026-10-20)
Details such as timings and fees can change, so please confirm with the clinic before you visit. If you are this doctor and something is out of date, request an update. Spotted a mistake? Tell us.
Questions about Dr. Narendra Agrawal
What are Dr. Narendra Agrawal's qualifications?
Dr. Narendra Agrawal holds a D.M. (Hematology) from All India Institute of Medical Sciences, Delhi, an M.D. from Jawahar Lal Nehru Medical College, Ajmer, Rajasthan, and an M.B.B.S. from Ravindra Nath Tagore Medical College, Udaipur, Rajasthan, both under the University of Rajasthan.
Where does Dr. Narendra Agrawal consult?
Dr. Narendra Agrawal works at Rajiv Gandhi Cancer Institute & Research Centre in Sector-5, Rohini, Delhi, as Sr. Consultant in Hemato Oncology & Bone Marrow Transplant.
Which conditions does Dr. Narendra Agrawal treat?
Dr. Narendra Agrawal treats blood cancers, including acute leukaemia (AML and ALL), lymphoma, myeloma and myelodysplastic syndromes, as well as anaemia, aplastic anaemia, bleeding and clotting disorders, thalassaemia, other haemoglobin disorders and haemophilia.
Other oncologists near Rohini
Dr. Sudhir Kumar Rawal
Chief of GenitoUro – Oncology Services, Uro-Genito Oncology
Dr. Sudhir Kumar Rawal, Uro-Genito Oncology at Rajiv Gandhi Cancer Institute & Research Centre, Delhi, with 36 years of experience and an M.Ch. (Urology).
Dr. A.K. Dewan
Principal Director, Surgical Oncology
Dr. A.K. Dewan, Surgical Oncology at Rajiv Gandhi Cancer Institute & Research Centre, Delhi, with 40 years of experience in cancer surgery.
Dr. Shivendra Singh
Director, Surgical Oncology & Chief, GI & HPB Onco Surgery, GI & HPB Onco Surgery
Dr. Shivendra Singh, Oncology at Rajiv Gandhi Cancer Institute & Research Centre, Delhi, with 28 years of experience and a DNB (General Surgery).